Syndax Pharmaceuticals Inc., Syngene International Ltd. and Vitae Pharmaceuticals Inc. have patented menin (MEN1)/MLL interaction inhibitors reported to be useful for the treatment of cancer.
HYDERABAD, India – Multinationals and domestic companies are stepping up research in India, including working to leverage the country’s digital and entrepreneurial capabilities, to boost India’s capabilities and market share in more innovative biologic drugs.
HYDERABAD, India – Multinationals and domestic companies are stepping up research in India, including working to leverage the country’s digital and entrepreneurial capabilities, to boost India’s capabilities and market share in more innovative biologic drugs.